Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacterial Infections

Correlation of Temperature and Toxicity in Murine Studies of Staphylococcal Enterotoxins and Toxic Shock Syndrome Toxin 1

Bradley G. Stiles, Yvette G. Campbell, Robert M. Castle, Sara A. Grove
Bradley G. Stiles
Department of Immunology and Molecular Biology, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvette G. Campbell
Department of Immunology and Molecular Biology, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert M. Castle
Department of Immunology and Molecular Biology, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara A. Grove
Shippensburg University, Shippensburg, Pennsylvania 17257
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.67.3.1521-1525.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

This study describes a quick (<12 h) assay for detecting temperature decreases in BALB/c and C57BL/6 mice injected intraperitoneally (i.p.) with staphylococcal enterotoxin A (SEA), SEB, or SEC3 or toxic shock syndrome toxin 1 and a potentiating dose of lipopolysaccharide (LPS). Toxin-specific antisera effectively neutralized the temperature fluctuations in this model. Orally administered SEA or SEB (50 μg/animal), with or without LPS, did not have an effect on temperature or lethality. Versus wild-type mice, transgenic knockout mice lacking the p55 receptor for tumor necrosis factor (TNF) or gamma interferon were protected against an i.p. challenge of SEA plus LPS. The p75 receptor for TNF and intercellular adhesion molecule 1 have a negligible role in this toxic shock model.

Staphylococcus aureuscauses many diseases in humans (6), and superantigens like the staphylococcal enterotoxins (SEs) plus toxic shock syndrome toxin 1 (TSST-1) are considered important virulence factors that induce immunosuppression in a host, thus providing a distinctly advantageous scenario for a pathogen (11, 25). Current in vivo investigations with the SEs and TSST-1 have vigorously concentrated on murine models (9, 20, 28, 32). Relative to the monkey emetic (36) or rabbit (7) models, mice afford an inexpensive alternative for studying (i) the in vivo effects of the SEs and TSST-1, (ii) neutralizing antibodies and therapeutics used against the SEs and TSST-1, and (iii) recombinantly attenuated SEs and TSST-1 used as vaccine candidates (1, 32, 33, 39, 40).

Various groups have shown that bacterial endotoxin plays a role in augmenting the biological activities of SEs, TSST-1, or streptococcal pyrogenic exotoxins (3, 8, 15, 16, 18, 24, 26, 27, 30, 34, 35), possibly by preventing superantigen-induced death of T cells (38) and thus sustaining a continued, potentially lethal release of proinflammatory cytokines. Previous studies with different SEs and TSST-1 in an LPS-potentiated murine model reveal a strong correlation between toxicity and increased serum levels of proinflammatory cytokines, like interleukins 1 and 6 (IL-1 and IL-6, respectively), tumor necrosis factor (TNF), and gamma interferon (IFN-γ) (32, 33, 39), that play a pivotal role in superantigen-mediated shock (21). Subsequent vaccine efforts with SEA (1), SEB (39, 40), and TSST-1 (33) have also been quite successful in this murine model.

In this report, different SEs and TSST-1 were given orally or injected intraperitoneally (i.p.) into LPS-potentiated mice to determine if body temperature represented a quick and reliable indicator of intoxication. Additional work established the effectiveness of passively administered antiserum in preventing toxin-induced fluctuations of temperature. Finally, experiments in transgenic knockout mice further defined the role of individual cytokines and a lymphocyte adhesion molecule in this model for staphylococcal superantigenic shock.

Purified staphylococcal toxins (Toxin Technology, Sarasota, Fla.) andEscherichia coli LPS (O55:B5) (Difco Laboratories, Detroit, Mich.) were reconstituted in sterile, pyrogen-free phosphate-buffered saline (PBS [pH 7.4]) and stored at −50°C. The endotoxin levels of all toxin preparations were determined by a Limulusamebocyte lysate assay (BioWhittaker, Walkersville, Md.) and contained <1 ng of endotoxin/mg of protein.

Male BALB/c and C57BL/6 mice (18 to 20 g) were housed in a specific-pathogen-free environment. Sterile temperature-identification transponders (IPTT-100) were purchased from Biomedic Data Systems (Maywood, N.J.) and implanted subcutaneously. As previously described (32), mice (n = 6 to 10 per group) were each injected i.p. at zero hour with a SE or TSST-1, followed 4 h later with 80 or 170 μg of LPS for BALB/c or C57BL/6 mice, respectively. Two different strains were used for our studies, because C57BL/6 mice express a different isotype (H-2b) of the class II major histocompatibility complex versus the BALB/c strain (H-2d) , and this can have a profound effect upon the in vitro and in vivo properties of these toxins (22, 31, 32, 33, 37). Temperatures were recorded every hour, for a total of 12 h. Tables 1 and2, respectively, show the temperature results in BALB/c and C57BL/6 mice following an i.p. injection of SEA, SEB, SEC3, or TSST-1. All of these toxins produced significant hypothermic effects within 12 h, relative to uninjected controls or mice given bovine serum albumin (BSA) plus LPS or PBS plus LPS. Although deaths were recorded by 72 h for all toxins tested, there was no lethality within the initial 12-h period of any experiment. The temperature decreases in BALB/c mice were most dramatic with SEB and TSST-1, whereas SEA was more effective in the C57BL/6 strain.

View this table:
  • View inline
  • View popup
Table 1.

Temperature effects of staphylococcal toxins on BALB/c mice

View this table:
  • View inline
  • View popup
Table 2.

Temperature effects of staphylococcal toxins on C57BL/6 mice

The temperature effects of orally administered SEA and SEB were also tested in C57BL/6 and BALB/c mice, respectively. Recent work by Blank et al. (5) reveals that mice injected intravenously with SEB (25 μg) plus LPS (50 μg) develop apoptotic epithelial cells lining the colon and jejunum crypts within 16 h. In our model, mice injected i.p. with a sufficient dose of any SE plus LPS develop diarrhea. The oral effects (via gavage) of SEA or SEB at 50 μg/mouse were tested 5 to 10 min after the stomach acidity was neutralized with 0.2 M NaHCO3. The potentiated effects of LPS (80 and 170 μg administered to BALB/c and C57BL/6 mice, respectively) were tested orally and by an i.p. injection at 4 h after the toxin dose. No temperature fluctuations, diarrhea, or death was attributed to orally administered SEA or SEB, with or without LPS.

Upon establishing that hypothermia was a reliable parameter of SE or TSST-1 intoxication in mice following an i.p. injection, the next series of experiments determined if this effect was neutralized by toxin-specific antiserum. Goat anti-SEA, anti-SEB, or normal sera (200 μl/mouse) were premixed with SEA or SEB (2 μg/mouse) for 1 h at room temperature before an i.p. injection. Figure1 shows that the temperature decrease was effectively neutralized in LPS-potentiated mice given hyperimmune serum, relative to that in controls administered toxin plus normal serum. Statistically significant differences in temperature were detected within 6 h and extended to 12 h, thus confirming the utility of temperature as a reliable and quick parameter for antibody neutralization studies.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Neutralization of SEA- or SEB-induced temperature decreases among BALB/c mice with anti-SEA or anti-SEB sera. N.S., normal sera. The numbers of dead (D) versus alive (A) mice were recorded at the 72-h time point and appear in parentheses.

Previous experiments with BALB/c or C57BL/6 mice suggest that levels of particular cytokines (IL-1, IL-6, TNF, and IFN-γ) in serum are elevated after an injection of SE or TSST-1 and a potentiating dose of LPS (32, 33, 39). To determine the role of individual cytokines or lymphocyte adhesion molecules like intercellular adhesion molecule 1 (ICAM-1) in temperature-based experiments, transgenic knockout C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine) were injected with SEA (10 μg) plus 170 μg of LPS (Table3). Based on temperature and lethality, the molecules that had the most profound effect (i.e., protection) in this model when deleted were p55 TNF receptor > IFN-γ > p75 TNF receptor > ICAM-1 > IL-10. Although there was no difference in lethality or temperature among mice lacking IL-10 versus those of the wild type, all of the IL-10 knockout mice died within 24 h, which was quicker than the time frame of 24 to 58 h for the wild type. The SEA and LPS were necessary for an effect in IL-10 knockout mice, because PBS plus LPS (170 μg/animal) or SEA alone (100 μg/animal) did not elicit a temperature drop or lethality. These results correspond to previous studies suggesting that IL-10 has a protective role in SEB-induced shock, probably via down regulation of IL-1, IL-2, IL-6, TNF-α, and IFN-γ (2, 12, 13, 17).

View this table:
  • View inline
  • View popup
Table 3.

Temperature effects of SEA plus LPS on transgenic knockout mice

In contrast to IL-10 knockout mice, the p55 TNF receptor and IFN-γ knockout mice were highly protected against the temperature and lethal effects of SEA plus LPS, thus suggesting that these molecules play an important role in toxicity. Previous studies with SEB or TSST-1 (19, 20) show that a neutralizing monoclonal antibody against TNF-α affords protection in ad-galactosamine-potentiated murine model. The p55 receptor for TNF also plays a major role in another LPS-potentiated murine model for SEB (5). Earlier studies report substantially increased amounts of TNF in mouse serum after an injection of SEA, SEB, or TSST-1 plus LPS (32, 33, 40), relative to those in controls given LPS alone, and this elevated level of TNF correlates well with lethality. Additionally, the experiments with IFN-γ knockout mice agree with previous studies showing that neutralizing antibodies against IFN-γ prevent superantigen-induced lethality (5, 12, 17). The role of IFN-γ in the superantigen-LPS synergy may lie in upregulation of the class II major histocompatibility complex and activation of STAT1 molecules that bind to promoter regions of various cytokine genes (5).

The final experiments were done with fas antigen-defective mice that hyperproduce the murine Vβ8.2 T-cell receptor (23). The T lymphocytes from these animals do not undergo superantigen-induced apoptosis and therefore continually produce potentially lethal concentrations of proinflammatory cytokines. It was hypothesized that a temperature deflection would be detected in these mice without a potentiating component like LPS. However, a 100-μg dose of SEB (i.p.) did not have any effect on temperature or lethality in our studies.

Temperature studies seem appropriate for these pyrogenic exotoxins, because they induce fever and in severe cases elicit a subsequent hypothermia, shock, and possibly death (4, 7). Besides abdominal cramps, vomiting, and diarrhea, victims of staphylococcal food poisoning often have a concomitant decrease in temperature (4). A previous report shows that rabbits given TSST-1 plus endotoxin (29), or TSST-1 alone (7), develop hypothermia following a transient fever. A recent study with rabbits injected with SEA alone reveals that the fever response is linked to increased levels of IFN-γ, TNF, IL-1, IL-2, and IL-6 in serum (14). In our murine studies, we did not see a temperature increase with the SEs or TSST-1, with or without LPS. However, proinflammatory cytokines like IFN-γ, TNF, IL-1, and IL-6 are maximally produced in the sera of LPS-potentiated mice within 6 to 8 h after a toxin injection (32, 33, 39, 40).

The hypothermic effects of endotoxin in rats (10), and probably mice (13), are linked to TNF concentrations which are greatly elevated in the LPS-potentiated mouse model for various staphylococcal superantigens (32, 33, 39). However, our current study clearly revealed that the LPS alone had negligible effects on temperature or lethality. There was an obvious synergistic effect between SEs or TSST-1 with LPS, which was easily detected by decreased temperatures. Additionally, the temperature fluctuations due to SEA or SEB were neutralized with toxin-specific antiserum, thus providing a quick in vivo method for determining antibody efficacy. The utility of a temperature-based murine model for testing vaccines against bacterial superantigens is currently being investigated by this laboratory.

ACKNOWLEDGMENTS

The use of computer facilities at Shippensburg University was essential and much appreciated for timely statistical analysis of data. The fas antigen-defective mice were a kind gift of Carl Edwards. Goat anti-SEA and anti-SEB sera were generously provided by Mark Poli.

Notes

Editor: V. A. Fischetti

FOOTNOTES

    • Received 1 September 1998.
    • Returned for modification 17 November 1998.
    • Accepted 22 December 1998.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Bavari S.,
    2. Dyas B.,
    3. Ulrich R. G.
    Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.J. Infect. Dis.1741996338345
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Bean A. G. D.,
    2. Freiberg R. A.,
    3. Andrade S.,
    4. Menon S.,
    5. Zlotnik A.
    Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock.Infect. Immun.61199349374939
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Beezhold D. H.,
    2. Best G. K.,
    3. Bonventre P. F.,
    4. Thompson M.
    Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.Infect. Immun.55198728652869
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Bergdoll M. S.
    Enterotoxins Staphylococci and staphylococcal infections. Easmon C. S. F., Adlam C. 1983 559 598 Academic Press London, United Kingdom
  5. 5.↵
    1. Blank C.,
    2. Luz A.,
    3. Bendigs S.,
    4. Erdmann A.,
    5. Wagner H.,
    6. Heeg K.
    Superantigen and endotoxin synergize in the induction of lethal shock.Eur. J. Immunol.271997825833
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Bohach G. A.,
    2. Fast D. J.,
    3. Nelson R. D.,
    4. Schlievert P. M.
    Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.Crit. Rev. Microbiol.171990251272
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Bonventre P. F.,
    2. Thompson M. R.,
    3. Adinolfi L. E.,
    4. Gillis Z. A.,
    5. Parsonnet J.
    Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.Infect. Immun.561988135141
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Bulanda M.,
    2. Zaleska M.,
    3. Mandel L.,
    4. Talafantova M.,
    5. Travnicek J.,
    6. Kunstmann G.,
    7. Mauff G.,
    8. Pulverer G.,
    9. Heczko P. B.
    Toxicity of staphylococcal toxic shock syndrome toxin 1 for germ-free and conventional piglets.Rev. Infect. Dis.111989S248S253
    OpenUrl
  9. 9.↵
    1. Chen J. Y.-J.,
    2. Qiao Y.,
    3. Komisar J. L.,
    4. Baze W. B.,
    5. Hsu I.-C.,
    6. Tseng J.
    Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D.Infect. Immun.62199446264631
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Derijk R. H.,
    2. Berkenbosch F.
    Hypothermia to endotoxin involves the cytokine tumor necrosis factor and the neuropeptide vasopressin in rats.Am. J. Physiol.2661994R9R14
    OpenUrlPubMed
  11. 11.↵
    1. Fleischer B.
    Superantigens produced by infectious pathogens: molecular mechanism of action and biological significance.Int. J. Clin. Lab. Res.241994193197
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Florquin S.,
    2. Amraoui Z.,
    3. Abramowicz D.,
    4. Goldman M.
    Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice.J. Immunol.153199426182623
    OpenUrlAbstract
  13. 13.↵
    1. Gerard C.,
    2. Bruyns C.,
    3. Marchant A.,
    4. Abramowicz D.,
    5. Vandenabeele P.,
    6. Delvaux A.,
    7. Fiers W.,
    8. Goldman M.,
    9. Velu T.
    Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.J. Exp. Med.1771993547550
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Huang W. T.,
    2. Lin M. T.,
    3. Won S. J.
    Staphylococcal enterotoxin A-induced fever is associated with increased circulating levels of cytokines in rabbits.Infect. Immun.65199726562662
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Keane W. F.,
    2. Gekker G.,
    3. Schlievert P. M.,
    4. Peterson P. K.
    Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1.Am. J. Pathol.1221986169176
    OpenUrlPubMedWeb of Science
  16. 16.↵
    1. Kim Y. B.,
    2. Watson D. W.
    A purified group A streptococcal pyrogenic exotoxin. Physicochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock.J. Exp. Med.1311970611628
    OpenUrlAbstract
  17. 17.↵
    1. LeClaire R. D.,
    2. Kell W.,
    3. Bavari S.,
    4. Smith T.,
    5. Hunt R. E.
    Protective effects of niacinamide in staphylococcal enterotoxin B induced toxicity.Toxicology10719966981
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Luhm J.,
    2. Kirchner H.,
    3. Rink L.
    One-way synergistic effect of low superantigen concentrations on lipopolysaccharide-induced cytokine production.J. Int. Cytol. Res.171997229238
    OpenUrl
  19. 19.↵
    1. Miethke T.,
    2. Duschek K.,
    3. Wahl C.,
    4. Heeg K.,
    5. Wagner H.
    Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.Eur. J. Immunol.23199314941500
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Miethke T.,
    2. Wahl C.,
    3. Heeg K.,
    4. Echtenacher B.,
    5. Krammer P. H.,
    6. Wagner H.
    T cell mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.J. Exp. Med.17519929198
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Miethke T.,
    2. Wahl C.,
    3. Regele D.,
    4. Gaus H.,
    5. Heeg K.,
    6. Wagner H.
    Superantigen mediated shock: a cytokine release syndrome.Immunobiology1891993270284
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Mollick J. A.,
    2. Chintagumpala M.,
    3. Cook R. G.,
    4. Rich R. R.
    Staphylococcal exotoxin activation of T cells: role of exotoxin-MHC class II binding affinity and class II isotype.J. Immunol.1461991463468
    OpenUrlAbstract
  23. 23.↵
    1. Mountz J. D.,
    2. Baker T. J.,
    3. Borcherding D. R.,
    4. Bluethmann H.,
    5. Zhou T.,
    6. Edwards C. K.
    Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock.J. Immunol.155199548294837
    OpenUrlAbstract
  24. 24.↵
    1. Murai T.,
    2. Nakagawa Y.,
    3. Ogawa Y.
    Potentiation of lethal endotoxin shock by streptococcal pyrogenic exotoxin in rabbits: possible relevance of hyperreactivity of macrophages to endotoxin.FEMS Immunol. Med. Microbiol.131996269272
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Muraille E.,
    2. De Smedt T.,
    3. Andris F.,
    4. Pajak B.,
    5. Armant M.,
    6. Urbain J.,
    7. Moser M.,
    8. Leo O.
    Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by Vβ-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.J. Immunol.158199726382647
    OpenUrlAbstract
  26. 26.↵
    1. Parsonnet J.,
    2. Gillis Z. A.
    Production of tumor necrosis factor by human monocytes in response to toxic shock syndrome toxin-1.J. Infect. Dis.158198810261033
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Priest B. P.,
    2. Schlievert P. M.,
    3. Dunn D. L.
    Treatment of toxic shock syndrome with endotoxin-neutralizing antibody.J. Surg. Res.461989527531
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Sarawar S. R.,
    2. Blackman M. A.,
    3. Doherty P. C.
    Superantigen shock in mice with an inapparent viral infection.J. Infect. Dis.170199411891194
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Schlievert P. M.
    Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.Infect. Immun.361982123128
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Schlievert P. M.,
    2. Watson D. W.
    Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.Infect. Immun.211978753763
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Scholl P. R.,
    2. Diez A.,
    3. Karr R.,
    4. Sekaly R. P.,
    5. Trowsdale J.,
    6. Geha R. S.
    Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.J. Immunol.1441990226230
    OpenUrlAbstract
  32. 32.↵
    1. Stiles B. G.,
    2. Bavari S.,
    3. Krakauer T.,
    4. Ulrich R. G.
    Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release.Infect. Immun.61199353335338
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Stiles B. G.,
    2. Krakauer T.,
    3. Bonventre P. F.
    Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.Infect. Immun.63199512291234
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Stone R. L.,
    2. Schlievert P. M.
    Evidence for the involvement of endotoxin in toxic shock syndrome.J. Infect. Dis.1551987682689
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Sugiyama H.,
    2. McKissic E. M.,
    3. Bergdoll M. S.,
    4. Heller B.
    Enhancement of bacterial endotoxin lethality by staphylococcal enterotoxin.J. Infect. Dis.1141964111118
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Surgalla M. J.,
    2. Bergdoll M. S.,
    3. Dack G. M.
    Some observations of the assay of staphylococcal enterotoxin by the monkey-feeding test.J. Lab. Clin. Med.411953782788
    OpenUrlPubMedWeb of Science
  37. 37.↵
    1. Uchiyama T.,
    2. Saito S.,
    3. Inoko H.,
    4. Yan X.-J.,
    5. Imanishi K.,
    6. Araake M.,
    7. Igarashi H.
    Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.Infect. Immun.58199038773882
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Vella A. T.,
    2. McCormack J. E.,
    3. Linsley P. S.,
    4. Kappler J. W.,
    5. Marrack P.
    Lipopolysaccharide interferes with the induction of peripheral T cell death.Immunity21995261270
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Woody M. A.,
    2. Krakauer T.,
    3. Stiles B. G.
    Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.Vaccine151997133139
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Woody M. A.,
    2. Krakauer T.,
    3. Ulrich R. G.,
    4. Stiles B. G.
    Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.J. Infect. Dis.177199810131022
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Correlation of Temperature and Toxicity in Murine Studies of Staphylococcal Enterotoxins and Toxic Shock Syndrome Toxin 1
Bradley G. Stiles, Yvette G. Campbell, Robert M. Castle, Sara A. Grove
Infection and Immunity Mar 1999, 67 (3) 1521-1525; DOI: 10.1128/IAI.67.3.1521-1525.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correlation of Temperature and Toxicity in Murine Studies of Staphylococcal Enterotoxins and Toxic Shock Syndrome Toxin 1
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Correlation of Temperature and Toxicity in Murine Studies of Staphylococcal Enterotoxins and Toxic Shock Syndrome Toxin 1
Bradley G. Stiles, Yvette G. Campbell, Robert M. Castle, Sara A. Grove
Infection and Immunity Mar 1999, 67 (3) 1521-1525; DOI: 10.1128/IAI.67.3.1521-1525.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

bacterial toxins
Body Temperature
enterotoxins
Staphylococcus aureus
superantigens

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522